Mazdutide – Dual GLP-1/Glucagon Receptor Agonist | 10mg

Mazdutide – Dual GLP-1/Glucagon Receptor Agonist | 10mg | RUO Grade | BlueBiotech®

Product Overview

Mazdutide is an investigational dual agonist peptide that targets both the GLP-1 receptor and the glucagon receptor, offering a synergistic mechanism for weight loss, glucose homeostasis, and energy expenditure modulation. This compound mimics the effects of native incretins while leveraging glucagon’s thermogenic properties, making it a promising agent in the study of obesity, type 2 diabetes, and metabolic dysfunction.

Mazdutide represents a next-generation incretin-based molecule, similar in concept to tirzepatide and cotadutide, but designed for enhanced metabolic effects through dual receptor activation. Supplied by BlueBiotech® as a high-purity 10mg lyophilized powder, this RUO-designated peptide is manufactured in the USA under stringent quality control.

🔬 Learn More:

• Cell Metabolism – Dual GLP-1/Glucagon Agonists in Obesity Therapy

• Nature Reviews – Incretin Combinations in Metabolic Research

Key Features

• ✅ Dual agonist for GLP-1R and GCGR

• ✅ Designed to promote appetite suppression, lipolysis, and energy expenditure

• ✅ ≥99% purity (HPLC-verified)

• ✅ 10mg lyophilized peptide per vial

• ✅ Manufactured in the USA by BlueBiotech®

• ✅ Strictly for Research Use Only (RUO)

Specifications

• Compound Name: Mazdutide

• CAS Number: N/A (Investigational)

• Molecular Formula: Peptide-based (confidential structure)

• Content: 10mg per vial

• Purity: ≥99% (HPLC)

• Form: White/off-white lyophilized powder

• Solubility: Sterile water or acetic acid

• Storage: –20°C, dry and protected from light

• Shelf Life: 24 months unopened

• Classification: RUO (Research Use Only)

Research Applications

• Investigating dual incretin-based metabolic modulation

• Animal model studies for obesity and weight management

• Comparison with tirzepatide, semaglutide, and cotadutide

• Exploration of glucagon receptor-mediated thermogenesis

• Studies on insulin sensitivity, lipid profile, and liver fat reduction

⚠️ Compliance Statement

This product is strictly provided For Research Use Only. It is not approved for human or animal use, nor for any therapeutic, diagnostic, or clinical purpose. All users must ensure compliance with institutional and local regulations.

Tags / Keywords

Mazdutide RUO, GLP-1 Glucagon Dual Agonist, BlueBiotech Peptide, Obesity Research Compound, Weight Loss Peptide Tool, Energy Expenditure Peptide, Glucose Regulation Peptide, Incretin Analog RUO